Results 241 to 250 of about 1,116,836 (319)
Haze measurements were used to demonstrate the photocatalytic degradation of polystyrene and polymethylmethacrylate microplastics. Indeed, considering that after the degradation the amount of the particles will decrease and the shape will change, the haze will change and can be used as a validation of the degradation.
Rossella Greco+6 more
wiley +1 more source
Exploring the feasibility of using school food purchase data as a method to assess dietary intakes in secondary school aged pupils. [PDF]
Bradley J, Spence S.
europepmc +1 more source
Cottonseed Meal as a Substitute for Soybean Oil Meal in Poultry Rations ,
John W. West
openalex +1 more source
Abstract Sitafloxacin is a new antibiotic drug belonging to the fourth generation quinolone antibiotics. The aim of this study was to evaluate the pharmacokinetics (PK), safety profiles, and bioequivalence of test and reference 50‐mg sitafloxacin tablets under fasting and fed conditions.
Yongfang Lei+13 more
wiley +1 more source
A Western-Style Diet Influences Ingestive Behavior and Glycemic Control in a Rat Model of Roux-en-Y Gastric Bypass Surgery. [PDF]
Hoornenborg CW+7 more
europepmc +1 more source
Abstract Cytochrome P450 (CYP) 3A plays a significant role in fruquintinib metabolism in vitro. This 2‐part, 2‐period fixed‐sequence study investigated the impact of CYP3A inhibition (itraconazole) and CYP3A induction (rifampin) on the pharmacokinetics (PK) of fruquintinib and M11, its main metabolite.
Martha Gonzalez+5 more
wiley +1 more source
The effect of meal replacements therapy on blood pressure and C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Fotros D+5 more
europepmc +1 more source
Abstract RBN‐3143 is an inhibitor of PARP14 in development for inflammatory diseases. Multiple assessments were conducted to evaluate the clinical pharmacology properties of RBN‐3134. A randomized, double‐blind, placebo‐controlled study assigned healthy volunteers (HVs) to single ascending doses (SADs) (25‐1000 mg) or multiple ascending doses (MADs ...
Thomas M. Polasek+9 more
wiley +1 more source